Detalles de la búsqueda
1.
Health Utility Analysis of Tepotinib in Patients With Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping.
Value Health
; 26(8): 1155-1163, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36805576
2.
Modelling the Effectiveness of Tepotinib in Comparison to Standard-of-Care Treatments in Patients with Advanced Non-small Cell Lung Cancer (NSCLC) Harbouring METex14 Skipping in the UK.
Target Oncol
; 19(2): 191-201, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38492157
3.
Modelling Survival of Patients Treated with Adjuvant Nivolumab Who Have Melanoma with Lymph Node Involvement or Metastatic Disease After Complete Resection.
Pharmacoecon Open
; 4(2): 343-351, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31587138
4.
Cost-effectiveness of Pembrolizumab for Patients with Advanced, Unresectable, or Metastatic Urothelial Cancer Ineligible for Cisplatin-based Therapy.
Eur Urol Oncol
; 2(5): 565-571, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31412011
Resultados
1 -
4
de 4
1
Próxima >
>>